Atyr PHARMA INC (NASDAQ:ATYR) Receives $18.60 Consensus PT from Brokerages
Shares of Atyr PHARMA INC (NASDAQ:ATYR – Get Free Report) have been given a consensus recommendation of “Buy” by the seven ratings firms that are covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month […]
Shares of Atyr PHARMA INC (NASDAQ:ATYR – Get Free Report) have been given a consensus recommendation of “Buy” by the seven ratings firms that are covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month […]
